Urmi Chatterji
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 20, 2025
Precise targeting of transcriptional co-activators YAP/TAZ annihilates chemoresistant brCSCs by alteration of their mitochondrial homeostasis.Priyanka Dey Talukdar, Kunal Pramanik, Priya Gatti
|Jan 24, 2025
Targeting breast cancer stem cells in ER-positive breast cancer by repurposing the benzoporphyrin derivative verteporfin as a YAP/TAZ small molecule inhibitor.Priyanka Dey Talukdar, Himansu Roy, Urmi Chatterji
|Nov 12, 2023
Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases.Priyanka Dey Talukdar, Urmi Chatterji
|Sep 05, 2022
PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTOR.Pritha Mukherjee, Arka Bagchi, Ananya Banerjee
|Mar 15, 2018
Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT.Tulika Mitra, Parash Prasad, Pritha Mukherjee
|Apr 05, 2017
All-Trans Retinoic Acid Ameliorates Arsenic-Induced Oxidative Stress and Apoptosis in the Rat Uterus by Modulating MAPK Signaling Proteins.Aniruddha Chatterjee, Urmi Chatterji
Pageof 2
